The Latest Breaking News from Vaccine

Epidemiologist Dr. Seth Berkley spoke to Live Science about the importance of vaccine equity and the obstacles undermining it, as well as the political challenges to vaccines being raised in the U.S.

CSL shares have tumbled more than 15 per cent to their lowest level since 2018 after it cut its profit forecast given falling US flu vaccine rates.

Vaccine production must be expanded to combat this ancient disease, especially in Africa, but a lack of political will is holding us back

Their predictions that millions, even billions would die haven't borne out.

The recent confirmation of new measles cases unconnected to international travel suggests the highly contagious disease has likely started spreading through communities, according to Health New Zealand.

Moderna, Inc. (NASDAQ:MRNA) revealed topline results on Wednesday from a Phase 3 trial evaluating the efficacy of mRNA-1647, the company’s investigational cytomegalovirus (CMV) vaccine. CMV is a herpes virus. Those who are pregnant or have compromised immune systems are most at risk from CMV.

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we and our colleagues published in the journal Nature.

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors

Cancer patients who received the mRNA-based jab after starting immunotherapy lived significantly longer than those who did not get the vaccine.